Skip to main content
. 2012 Apr 16;119(23):5522–5531. doi: 10.1182/blood-2011-11-392571

Figure 3.

Figure 3

Mx-Cre deletion of Spry1 worsens, and prolongs, hemolysis-induced anemia. (A) Conditional Spry1−/− and wild-type control mice were challenged by hemolysis (phenylhydrazine [PHZ]; 70 mg/kg). At the indicated intervals, red cell mass was assayed (hematocrits). Values are mean ± SE (n = 4). (B) Analyses of erythroid cells in spleen at day 3.5 after phenylhydrazine revealed an approximate 270% elevation in frequencies of Spry1-deficient stage E1 progenitors.